HFA Premium Access

Can SGLT2i use decrease the risk of atrial fibrillation in patients with heart failure with reduced ejection fraction: a retrospective cohort study

Congress Presentation

About the speaker

Doctor Joel Manuel Alejandro

University of Maryland, Baltimore (United States of America)
1 follower

3 more presentations in this session

Tricuspid regurgitation disease stages and treatment outcomes after transcatheter tricuspid valve repair

Speaker: Doctor F. Schlotter (Mainz, DE)

Thumbnail

Heart Failure and autoimmune disease: a Nationwide Cohort Study

Speaker: Ms G. Sun (Copenhagen, DK)

Thumbnail

Effects of dapagliflozin on new-onset diabetes in patients with heart failure: a pooled, participant-level analysis of the DAPA-HF and DELIVER trials

Speaker: Doctor M. Lassen (Boston, US)

Thumbnail

Access the full session

Young Investigator Award (YIA) Clinical Cardiology

Speakers: Doctor J. Alejandro, Doctor F. Schlotter, Ms G. Sun, Doctor M. Lassen
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations